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Mutations in VPS33B and VIPAS39 cause the severe multisystem disorder Arthrogryposis, Renal dysfunction and
Cholestasis (ARC) syndrome. Amongst other symptoms, patients with ARC syndrome suﬀer from severe ich-
thyosis. Roles for VPS33B and VIPAR have been reported in lysosome-related organelle biogenesis, integrin
recycling, collagen homeostasis and maintenance of cell polarity. Mouse knockouts of Vps33b or Vipas39 are
good models of ARC syndrome and develop an ichthyotic phenotype. We demonstrate that the skin manifes-
tations in Vps33b and Vipar deﬁcient mice are histologically similar to those of patients with ARC syndrome.
Histological, immunoﬂuorescent and electron microscopic analysis of Vps33b and Vipar deﬁcient mouse skin
biopsies and isolated primary cells showed that epidermal lamellar bodies, which are essential for skin barrier
function, had abnormal morphology and the localisation of lamellar body cargo was disrupted. Stratum corneum
formation was aﬀected, with increased corneocyte thickness, decreased thickness of the corniﬁed envelope and
reduced deposition of lipids. These defects impact epidermal homeostasis and lead to abnormal barrier forma-
tion causing the skin phenotype in Vps33b and Vipar deﬁcient mice and patients with ARC syndrome.
1. Introduction
Patients with mutations in the genes VPS33B and VIPAS39 have
been reported with Arthrogryposis, Renal dysfunction and Cholestasis
(ARC) syndrome (OMIM #208085 and #613404) [1,2]. ARC syndrome
is a rare autosomal recessive multisystem disorder and patients char-
acteristically present with arthrogryposis, renal proximal tubule dys-
function, neonatal cholestasis and severe failure to thrive [3]. Patients
also present with other symptoms as part of this syndrome including
ichthyosis, sensorineural deafness, abnormal platelet α-granule bio-
synthesis, osteopenia, absent corpus callosum, recurrent infections and
mild dysmorphia [3]. The majority of those aﬀected by ARC syndrome
die in infancy, generally from sepsis, dehydration, or acidosis caused by
recurrent infections [4], however, a few patients have been reported to
survive until childhood with an attenuated ARC syndrome phenotype
[5,6].
We recently described Autosomal Recessive Keratoderma Ichthyosis
Deafness (ARKID) syndrome, a syndrome allelic to ARC syndrome,
caused by a novel missense mutation in VPS33B: c.
[392G > A;390G > A] p.Gly131Glu, patients with ARKID syndrome
also present with symptoms including severe palmoplantar hyperker-
atosis [7]. Although patients with VPS33B and VIPAR deﬁciencies de-
velop dry scaly skin conditions both as part of ARC syndrome [3] or the
newly identiﬁed ARKID syndrome [7], the underlying cause of the skin
disease has not yet been determined.
The uppermost layer of the skin is a highly organised stratiﬁed
epithelium formed of four distinct layers of keratinocytes. In the basal
layer, the stratum basale (SB), keratinocytes proliferate and their
daughter cells populate the upper layers. These cells diﬀerentiate into
cells of the spinous layer, the stratum spinosum (SS), cells of the
granular layer, the stratum granulosum (SG), and then into cells of the
uppermost layer, the stratum corneum (SC), losing their organelle
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contents and becoming progressively corniﬁed as they diﬀerentiate into
enucleate corneocytes [8]. Formation of the SC is heavily dependent on
lamellar bodies (LBs), lysosome-related organelles produced in SG
keratinocytes and secreted at the junction between the SG and SC.
Amongst other cargo LBs contain lipids and lipid modifying enzymes
which contribute to the formation and homeostasis of the SC [9].
Previous analysis of the ultrastructure of skin from patients with
ARC syndrome identiﬁed unexpected lipid bilayer structures and in-
clusions in the SC of patients with a VPS33B mutation: c.701-1G > C
p.Asp234His, which leads to truncation of the VPS33B protein [10].
These structures were not present in the SC of healthy human controls
and Hershkovitz et al. attributed the abnormal lamellar structures in the
SC to the inability of LBs to secrete their contents at the SG-SC junction,
leading to “entombed lamellar granules” [10]. Biopsies from patients
with ARKID syndrome and mice deﬁcient for Vps33b also demonstrated
abnormal LB structures in the SG and retention of lipid layers in the SC,
which further indicates defects in LB function in VPS33B deﬁciency [7].
The proteins encoded by the genes VPS33B and VIPAS39, VPS33B
and VIPAR respectively, interact and are hypothesized to act as reg-
ulators of intracellular vesicular fusion events [2,11,12]. VPS33B and
VIPAR proteins show a high degree of similarity to their yeast homo-
logues Vps33p and Vps16p, which are required for protein traﬃcking to
the yeast vacuole [13] as components of the class c core vacuole/en-
dosome tethering (CORVET) and homotypic fusion and vacuole protein
sorting (HOPS) multiprotein complexes [14]. Metazoans have two other
homologues of Vps33p and Vps16p: VPS33A and VPS16A. VPS33A and
VPS16A interact and act as components of the mammalian HOPS and
CORVET complexes [15–17] whilst VPS33B and VIPAR are thought to
act as a component of a distinct and as yet only partly characterised
tethering complex, the class C homologues in endosome-vesicle inter-
action (CHEVI) complex [11,12].
The epidermal defects of patients with ARC and ARKID syndromes
could be a direct eﬀect of deﬁcient VPS33B-VIPAR traﬃcking; in LB
biogenesis and secretion a tethering complex could be important for
delivery of cargo proteins to LBs or important for tethering and secre-
tion of LBs at the plasma membrane. As keratinocytes in the SG dif-
ferentiate they secrete LBs at their apical surface, at the interface with
the SC [18], and as the keratinocytes diﬀerentiate into corneocytes of
the SC their intracellular structures are degraded through release of
lysosomal enzymes [8]. The “entombed” LBs described by Hershkovitz
et al. [10], could therefore be due to deﬁciency of the VPS33B-VIPAR
tethering complex in secretion of LB contents, in the biogenesis of LBs,
which could aﬀect their secretion, or could also be caused by defects in
degradation of intracellular organelles.
The VPS33B-VIPAR complex has previously been reported to have
diverse functions, from α-granule formation in megakaryocytes [5,19],
platelet integrin recycling [20], delivery of a collagen modifying en-
zyme, LH3, to collagen in kidney cells and ﬁbroblasts [21], Rab11a-
dependent apical protein targeting in hepatocytes [2,22] to exosome
maturation [23]. Therefore, the epidermal defects of patients with ARC
and ARKID syndromes could be an indirect eﬀect of defects in pre-
viously described VPS33B-VIPAR complex functions, for example, epi-
dermal defects may be secondary to alterations in LH3-dependent col-
lagen modiﬁcation, leading to altered basal lamina structure or
alterations in apical protein targeting. This could aﬀect diﬀerentiation
and downstream signalling, or establishment of polarity that could
impact LB biogenesis and secretion.
Several groups have generated murine models to better understand
the pathophysiology of ARC syndrome, however, constitutive and early
embryonic Vps33b knockout is lethal [5,19]. We generated tamoxifen-
inducible ubiquitous Vps33b and Vipar knockout mice: Vps33bﬂ/ﬂERT2
and Vipas39ﬂ/ﬂERT2 mice and induce knockout 4–5weeks after birth
[5,21]. The mice do not develop some phenotypes associated with ARC
syndrome, such as visible joint contractures or severe renal dysfunction,
possibly due to induction of the knockout post-development. However,
both Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice develop dry scaly skin,
and alterations in LB and SC ultrastructure have been reported in
Vps33bﬂ/ﬂERT2 epidermis [3,5,21]. How VPS33B and VIPAR deﬁciency
aﬀects epidermal homeostasis and LB secretion, has yet to be de-
termined. In order to better understand the underlying causative me-
chanisms of the dry skin phenotype in patients with ARC and ARKID
syndromes, we analysed the histology of the skin in our Vps33b and
Vipar deﬁcient mice and investigated the eﬀects of VPS33B and VIPAR
deﬁciency on the function of epidermal junctions, structure of dermal
collagen and function of epidermal LBs.
2. Materials and methods
2.1. Antibodies and reagents
The following primary antibodies were used: anti-β-catenin
(ab2365, Abcam), anti-claudin-1 (717800, ThermoFisher), anti-cleaved
caspase-3 (9661S Cell Signalling), anti-collagen I (NB600-408, Novus
Biologicals), anti-E-cadherin (610181, BD Biosciences), anti-K6A
(905701, Biolegend), anti-K10 (905401, Biolegend), anti-K14 (ab7800,
Abcam), anti-Ki67 (ab15580, Abcam) and anti-KLK5 (MAB7236, R&D
Systems). All ﬂuorescent secondary antibodies were Alexa Fluor con-
jugates (Life Technologies, UK). All reagents were from Sigma-Aldrich
unless stated.
2.2. Vps33bﬂ/ﬂ-ERT2 and Vipas39ﬂ/ﬂ-ERT2 mice and trans-epidermal water
loss (TEWL) measurements
Tamoxifen induction of the exon knockouts in Vps33bﬂ/ﬂ-ERT2 and
Vipas39ﬂ/ﬂ-ERT2 mice have been described previously [5,7,21]. Control
mice are either Vps33b+/+ or Vipas39+/+; tamoxifen injection did not
cause a skin phenotype and therefore the control mice were not injected
with tamoxifen. Where control mice are indicated results from
Vps33b+/+ and Vipas39+/+ mice were pooled due to invariability of
results. United Kingdom Home Oﬃce approval was obtained for all
experiments, licence number PPL 70/7470, in accordance with the
Animals (Scientiﬁc Procedures) Act of 1986. Photos were obtained with
the permission of the Named Veterinary Surgeon of the Biological
Services Unit of UCL. TEWL measurements across murine ventral ab-
domen were performed with a VapoMeter (Delﬁn Technologies) ac-
cording to the manufacturer's instructions; fur was cut short with an
electric hair trimmer immediately prior to the readings and the average
of three measurements per mouse was used.
2.3. Primary murine keratinocyte isolation, maintenance and stratiﬁcation
In a method adapted from Lichti et al. [24] primary murine kera-
tinocytes were isolated from control, Vps33bﬂ/ﬂ-ERT2 and Vipas39ﬂ/ﬂ-
ERT2 tail skin. The ﬁnal cell suspension was diluted to 2.5×105 cells/
ml for control cells and 3×105 cells/ml for Vps33bﬂ/ﬂ-ERT2 and Vi-
pas39ﬂ/ﬂ-ERT2 cells for seeding on ﬁbronectin coated dishes. Cells were
grown at 37 °C, 5% CO2 in a humidiﬁed atmosphere. Primary murine
keratinocytes were stratiﬁed with CnT-Prime-3D (CELLnTEC) according
to the manufacturer's protocol: keratinocytes at 5× 105 cells/ml in
CnT-Prime (CELLnTEC) were seeded in polyester 0.4 μm Transwell in-
serts (Corning), at conﬂuency, CnT-Prime was replaced with CnT-
Prime-3D and the following day the insert raised to the air-liquid in-
terface and cultured for 12 days.
2.4. Trans-epithelial electrical resistance measurements of stratiﬁed primary
keratinocyte cultures
Fresh media was added outside and inside Transwell inserts con-
taining stratiﬁed keratinocyte cultures, as described in Section 2.2, and
equilibrated for 30min. Readings were taken with a SSTX01 electrode
(Millipore) connected to a Millicell ERS-2 Voltohmmeter (Millipore)
according to the manufacturer's protocol. Resistance was calculated as
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raw resistance subtracted by the average resistance of two empty in-
serts. Duplicate well measurements were averaged. The Unit Area Re-
sistance (Ωcm2) was calculated as the product of the resistance and
surface area of the inserts.
2.5. Primary murine ﬁbroblast isolation and culture
Fibroblasts were isolated from dermal samples generated during
keratinocyte isolation, see Section 2.2, which were minced and in-
cubated with 1×trypsin-EDTA at 37 °C with 5% CO2 for 20min. Ap-
proximately half the cell suspension was removed and trypsin-EDTA
inactivated in ﬁbroblast medium (DMEM high glucose with L-gluta-
mine, 15% FBS, 1× penicillin-streptomycin and 0.1 mM β-mercap-
toethanol). Fresh trypsin was added and the suspension returned to the
incubator. This was repeated 3–5 times. Remaining suspension was
collected through a 100 μm cell strainer and the suspension centrifuged
twice at 200g for 5min. The pellet was resuspended and plated into
suitable culture dishes.
2.6. Secreted extracellular matrix preparation from primary murine
ﬁbroblasts
In a method adapted from Caley et al. [25] conﬂuent primary
murine ﬁbroblasts were cultured with the addition of 100 μM ascorbic
acid for 10 days. The slides were decellularised and stained for collagen
I. The ImageJ Directionality plugin measured ﬁbre alignment [26].
2.7. Wound healing assays
Conﬂuent primary murine ﬁbroblasts were scratched with a 200 μl
pipette tip, held at 90° to the well surface. An EVOS XL Core wideﬁeld
light microscope (Life Technologies) was used to image the scratch at 0,
16 and 24 h. The area of the scratch was quantiﬁed using the BoneJ
ImageJ plugin [27].
2.8. Cell spreading assays
Primary murine keratinocytes or ﬁbroblasts at 1×105 cells/ml
were seeded into tissue cultured treated dishes, ﬁxed after 1 h and
stained with Alexa-labelled wheat germ agglutinin and DAPI. Three
images per experiment were analysed with CellProﬁler software [28].
2.9. Co-culture of primary murine keratinocytes and ﬁbroblasts for a full
thickness skin model
Primary murine ﬁbroblasts cultured in CnT-Prime Fibroblast
(CELLnTEC) were plated at 1×105 cells/ml into 0.4 μm pore Millicell
hanging cell culture inserts (Millipore). On day 9 or 10, CnT-Prime
Fibroblast was removed and primary murine keratinocytes were seeded
at 2× 105 cells/ml in CnT-Prime-FTAL (CELLnTEC). After three days
the inserts were lifted to the air-liquid interface and the models cultured
for 12 days.
2.10. Fixation, processing and histological staining of murine epidermal
tissue samples
Murine epidermal skin samples were frozen in optimum cutting
temperature compound in an isopentane bath cooled over liquid ni-
trogen or ﬁxed in 10% formalin. Formalin ﬁxed samples were paraﬃn
embedded, sectioned and processed for histological staining by the
Biomedical Research Centre at the Institute of Child Health, London,
UK. Hematoxylin and eosin (H&E) and picrosirius red stains were im-
aged on a Zeiss Axioplan2 microscope with a Zeiss AxioCam HRc colour
camera. Epidermal thickness was calculated using the BoneJ ImageJ
plugin [27]. The number of cells was counted using the ImageJ Cell
Counter plugin and reported per 100 μm of the dermal-epidermal
junction. Keratinocyte size was calculated as total epidermal area di-
vided by the number of keratinocyte nuclei.
2.11. Immunohistochemistry
Slides with paraﬃn embedded sections were stained as described
previously [22] and images taken with a Zeiss Axioplan2 ﬁtted with a
Zeiss Axiocam HRc colour camera.
2.12. Immunoﬂuorescent staining
Cryosections were ﬁxed in 4% PFA and −20 °C methanol, cell or
matrix cultures were ﬁxed in 4% PFA. Sections were quenched with
50mM ammonium chloride and permeabilised with 0.25% Triton X-
100. Blocking was performed with 1% goat or donkey serum in PBS
with 0.5% Triton X-100. Primary antibodies were diluted in blocking
solution and incubated overnight at 4 °C. Alexa-conjugated secondary
antibodies, also diluted in blocking solution, were incubated with
samples for 2 h at RT. Samples were counterstained with DAPI,
mounted with Prolong Gold (Life Technologies) and imaged on a Leica
TCS SP5 confocal microscope. Ki67 positive nuclei were counted using
the ImageJ Cell Counter plugin.
2.13. Oil red O (ORO) staining
Cryosections were ﬁxed in 4% PFA, washed with tap water and
incubated with 60% isopropanol for 5min. A 3mg/ml stock solution of
ORO in 100% isopropanol was diluted 3:2 in deionised water and ﬁl-
tered. Slides were incubated with ORO solution for 15min and rinsed
with tap water. Slides were counterstained with DAPI mounted in
Prolong Gold and imaged on a Leica TCS SP5 confocal microscope.
2.14. Transmission electron microscopy (TEM)
1.5mm mouse skin biopsies, ﬁxed in 4% glutaraldehyde (TAAB) in
0.1 M sodium phosphate, were prepared and imaged as described pre-
viously [7].
2.15. Statistics
All analyses were performed using GraphPad Prism 7. For the
comparison of two datasets, two-tailed unpaired t-tests were performed
and an F-test used to ensure that the variances were not signiﬁcantly
diﬀerent between the two datasets. To compare three or more data sets
an ordinary one-way ANOVA was performed and a Brown-Forsythe test
was used to ensure the variances were not signiﬁcantly diﬀerent be-
tween the datasets. A Tukey's multiple comparisons post-test was then
used to analyse diﬀerences between pairs of datasets. For analysis in
Fig. 2D, a non-parametric Kruskal-Wallis test was performed, with a
Dunn's multiple comparisons post-test.
3. Results
3.1. Vps33b and Vipar deﬁcient mice have a dry skin phenotype with
defective water barrier function
Three to four weeks after induction of the knockout both Vps33bﬂ/
ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice lose VPS33B or VIPAR protein expres-
sion in epidermal keratinocytes, Fig. 1A, and develop a visible dry ﬂaky
skin phenotype, Fig. 1B, with increased water loss, Fig. 1C, indicating a
disrupted barrier to water loss in Vps33b and Vipar deﬁcient mice.
The epidermis of Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice is thicker
than control epidermis, with increased thickness of the SB and SS
(acanthosis), the SG (hypergranulosis) and the SC (hyperkeratosis),
Fig. 1D, as previously reported in Vps33bﬂ/ﬂERT2 mice [7]. The epi-
dermal height increased from an average of 15.82 μm in controls to
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Fig. 1. Vps33b and Vipar deﬁcient mice develop dry skin with a defective water loss barrier that is characterised by hyperplasia and hyperproliferation. A - Control, Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 keratinocyte lysates blotted for VPS33B, VIPAR and GAPDH expression, arrows indicate VPS33B and VIPAR speciﬁc bands. B - Photos of dorsal skin of control, Vps33bﬂ/
ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice. Vps33bﬂ/ﬂERT2 photo reproduced from [5]. C - Trans-epidermal water loss (TEWL) of control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice. D - H&E staining of
control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin with increased purple granular staining, spongiosis (double arrows) and thicker SC (single arrow). E - Epidermal thickness of control,
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice, the distance from the dermal-epidermal junction to the SG-SC junction. F - The number of nuclei in the epidermis of control, Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 mice. G - Average keratinocyte size of control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice: epidermal area divided by number of nuclei. H - Representative Ki67 staining of
control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin sections, counterstained with DAPI. I - Quantiﬁcation of the number of Ki67 stained nuclei per mm of epidermis. Western blots are
representative of two independent western blotting experiments. Scale bars= 50 μm. Immunoﬂuorescent images are a maximum projection of a z-stack. For epidermal measurements
three ﬁelds of view were measured per mouse, the number of independent murine samples mice analysed (n) are indicated on the graphs. * p≤ 0.05, ** p≤ 0.01, **** p≤ 0.0001.
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69.13 and 75.04 μm in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice re-
spectively, Fig. 1E. This is inﬂuenced by an increase in keratinocyte
number (hyperplasia), from approximately 11 keratinocytes per 100 μm
to 28 and 31 keratinocytes per 100 μm, Fig. 1F, and an increase in
keratinocyte size, Fig. 1G. Control keratinocytes had an average size of
101.8 μm2, consistent with previously reported ﬁgures [29,30], but
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 keratinocytes were signiﬁcantly
larger with average areas of 202.9 and 204.6 μm2 respectively. There
was an increase in dark purple punctate “granular” staining in the
upper SG, indicating changes in the structure of SG cells, and gaps
between cells (spongiosis) in the SG and SS, Fig. 1D and Supplementary
Fig. 1A, which is a phenomenon previously noted to be associated with
the response of the epidermis to decreased barrier function [31,32].
Proliferation was increased in both Vps33b and Vipar deﬁcient mice
compared to control; there was an increase in the number of nuclei
expressing the proliferation marker Ki67, Fig. 1H and I, and increased
expression of hyperproliferation-associated keratin 6A (K6A) in
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis, Supplementary Fig. 1B.
There was no diﬀerence identiﬁed in the expression of the apoptotic
marker cleaved caspase-3, Supplementary Fig. 1C, suggesting epi-
dermal hyperplasia in Vps33b and Vipar deﬁcient mice is due to in-
creased keratinocyte proliferation.
3.2. Epidermal diﬀerentiation is aﬀected in Vps33b and Vipar deﬁcient
mice
All layers of the epidermis are formed in Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 epidermis, Fig. 1D, indicating that keratinocyte diﬀer-
entiation is occurring. However, the SG showed increased granular
staining and the SC was thicker in appearance, suggesting defects in
keratinocyte diﬀerentiation impacting cells of the SG and SC. In healthy
epidermis Fig. 2, keratin 14 (K14) is highly expressed in basal kerati-
nocytes and downregulated in the keratinocytes of the SS and SG [33],
Fig. 2A, and as K14 expression is downregulated in diﬀerentiating
keratinocytes the expression of K10 is upregulated [33], Fig. 2B.
However, in both Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis K14 is
not downregulated, Fig. 2A, although K10 is upregulated in suprabasal
keratinocytes, Fig. 2B. This indicates there are no defects in the upre-
gulation of expression of K10 but there may be other defects preventing
K14 downregulation in Vps33b and Vipar deﬁcient mice.
Keratinocyte diﬀerentiation culminates in the formation of the SC, a
corniﬁed layer consisting of enucleate corneocytes and intercellular
lipid lamellae [8]. Control corneocytes are compact, devoid of cellular
organelles and surrounded by a corniﬁed envelope, Fig. 2C. In Vps33bﬂ/
ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis the corneocytes are larger, Fig. 2D,
and contain lipid-like layers and other diverse structures, suggesting
defective keratinocyte terminal diﬀerentiation. Vps33bﬂ/ﬂERT2 and Vi-
pas39ﬂ/ﬂERT2 corneocytes also have thinner corniﬁed envelopes, at an
average of 14.53 nm and 15.03 nm respectively, compared to control
corneocytes at 19.8 nm, Fig. 2E, further supporting the conclusion that
there is a defect in terminal diﬀerentiation in Vps33b and Vipar deﬁ-
cient mice.
3.3. Epidermal junctions are unaﬀected in Vps33b and Vipar deﬁcient mice
Increased water loss across Vps33b and Vipar deﬁcient murine skin
indicates the water barrier function of the epidermis is defective in
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice, Fig. 1C. The epidermal water
barrier is made up of both epidermal junctions and SC lipid layers
[34,35]. VPS33B and VIPAR deﬁciencies aﬀect polarisation and for-
mation of tight junctions in epithelial cells [2,22], which suggests the
water barrier defect in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice may be
caused by defective junction formation, and defects in junction for-
mation can lead to barrier disruption [36–38].
However, the tight junction protein claudin-1 and the adherens
junction proteins E-cadherin and β-catenin in Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 epidermis localised to the plasma membrane, sug-
gesting that the junctions are forming correctly in Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 mice, Fig. 3A and B. Tight junction function was con-
ﬁrmed in vitro; trans-epithelial electrical resistance (TEER) across stra-
tiﬁed keratinocyte layers were not diﬀerent to control keratinocytes,
Fig. 3C and D, indicating the plasma membrane localised junctional
proteins are forming functional tight junctions.
Desmosomes, important for cell-cell adhesion and mechanical
strength in the epidermis also showed no overt change in ultrastructure
in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis, Fig. 3E. Further in-
dicating defects in the water barrier function of the epidermis in
Vps33b and Vipar deﬁcient mice are unlikely to be due to alterations in
epidermal junctions.
3.4. Vps33b and Vipar deﬁcient mice display subtle defects in basement
membrane formation and deposition of collagen I in vitro
We have recently shown that a collagen modifying enzyme, LH3, is
mislocalised in VPS33B and VIPAR deﬁcient mIMCD3 cells [21]. Al-
tered LH3 distribution was also observed in ﬁbroblasts from patients
with the p.Gly131Glu novel VPS33B mutation in ARKID syndrome,
with abnormal post-translational modiﬁcation of collagen lysine re-
sidues and deﬁciencies in the basement membrane of the dermo-epi-
dermal junction [7]. Knockout of LH3 in mice causes basement mem-
brane abnormalities [39] and it is possible that disruption in LH3
delivery could cause the epidermal defects in Vps33b and Vipar deﬁ-
cient mice, and patients with ARC syndrome, by disrupting extra-
cellular matrix formation, through deﬁciency of LH3-dependent col-
lagen modiﬁcations.
There were no gross changes in the morphology of collagen and
other ﬁbres of the dermis in picrosirius red stained sections of control,
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin, Fig. 4A. Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 dermal collagen ﬁbril size were also similar to those in
control mice, Fig. 4B. However, electron microscopy of the dermo-
epidermal junction showed areas of basement membrane that appeared
thinner in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice than in control mice
indicating defects in deposition or organisation of the basement mem-
brane, Fig. 4C, consistent with aﬀected LH3 function.
Primary murine ﬁbroblasts isolated from Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 mice secreted a more disorganised matrix in vitro,
Fig. 5A. The ‘directionality’ of matrices, or the tendency of the ﬁbres to
align, was higher in control cultures, producing a tighter Gaussian
distribution; the standard deviation of the Gaussian function was sig-
niﬁcantly higher in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 ﬁbroblasts,
Fig. 5B. The range of the Gaussian function, the maximum value minus
the minimum, indicating the number of ﬁbres aligned in the most
common direction compared to the least common direction, was much
lower in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 ﬁbroblasts, Fig. 5C. This
indicates ﬁbres were more dispersed than in control cultures, sug-
gesting changes in basement membrane deposition in vitro, consistent
with defects in LH3 delivery causing alterations in collagen modiﬁca-
tions and crosslinking.
Signiﬁcant abnormalities in ﬁbroblast deposition of collagen in vitro,
Fig. 5A–C, yet subtle defects in collagen structure in Vps33b and Vipar
deﬁcient mice, Fig. 4, may indicate the eﬀect of Vps33b and Vipar
deﬁciency on LH3 function is not the primary cause of the scaly skin
phenotype in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice.
Co-cultures of primary ﬁbroblasts and keratinocytes in a ‘full
thickness’ skin model demonstrated that the defect is primarily epi-
dermal. Control full thickness skin models stained for the lamellar body
cargo kallkrein 5, KLK5, showed strong punctate staining in suprabasal
keratinocytes, Fig. 5D. Whereas, KLK5 staining in knockout cultures
was decreased in intensity and was less frequent. KLK5 staining was
also decreased in intensity and frequency in control ﬁbroblast-knockout
keratinocyte cultures and knockout ﬁbroblast-control keratinocyte
cultures. This suggests the presence of control ﬁbroblasts cannot rescue
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epidermal defects in knockout keratinocytes and the defects are likely
to be due to an epidermal speciﬁc role of the VPS33B-VIPAR complex.
3.5. Vps33b and Vipar deﬁcient mice display subtle defects in integrin
function
VPS33B has been implicated in integrin endocytosis [20], to test
whether integrin dependent functions were aﬀected in Vps33b and
Vipar deﬁcient skin cells, we determined whether cell spreading and
wound healing were altered. Cell spreading was not aﬀected in VPS33B
or VIPAR deﬁcient primary keratinocytes or ﬁbroblasts, Supplementary
Fig. 2A–D. Wound healing was slower in Vps33bﬂ/ﬂERT2 primary ﬁ-
broblasts, Supplementary Fig. 2E and F, which may indicate subtle but
signiﬁcant defects in integrin recycling in Vps33bﬂ/ﬂERT2 epidermis.
3.6. Vps33b and Vipar deﬁcient mice have abnormal LB structures, altered
LB cargo expression and decreased SC lipids
The main barrier to water loss in the skin is the SC, corneocytes
surrounded by arrangements of lipid layers [40]. The water barrier
defect in Vps33b and Vipar deﬁcient mice may be due to defective SC
formation. Skin from patients with ARC syndrome and ARKID
syndrome, and Vps33bﬂ/ﬂERT2 murine models, show SC defects and
abnormalities in LBs [7,10]. Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice
have larger corneocytes and thinner corniﬁed envelopes, which may
indicate LB deﬁciencies as corniﬁed envelope formation is controlled by
LB contents, Fig. 2C–E.
LB ultrastructure is abnormal in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2
mice with bubble-like inclusions at the SG-SC interface, Fig. 6A. The LB
cargo, KLK5, normally secreted by LBs, was present in discrete puncta
in the suprabasal layers of control epidermis, Fig. 6B. However, in
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis KLK5 staining was de-
creased in intensity and more dispersed throughout the epidermis. This
suggests there is reduced expression of KLK5 in Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 epidermis, which may be linked to defects in delivery of
KLK5 to LBs.
Lipid deposition in the SC by LB was also aﬀected in Vps33b and
Vipar deﬁcient mice. In the SC of control epidermis there is strong
homogeneous staining in the SC for Oil Red O (ORO), which stains
neutral lipids, Fig. 6C. However, in the SC of Vps33bﬂ/ﬂERT2 and Vi-
pas39ﬂ/ﬂERT2 sections ORO staining was reduced and restricted to re-
gions of the SC that appeared to be arranged linearly, Fig. 6C. The
linearity may be due to the increase in size of the corneocytes that was
noted in these mice, Fig. 2E. Decreased intensity of ORO staining in
Fig. 2. Vps33b and Vipar deﬁcient mice have defects in terminal keratinocyte diﬀerentiation. A - K14 staining in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin sections, counterstained
with DAPI. Scale bars= 20 μm. Images are a maximum projection of a z-stack and are representative of results from at least six control and three Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2
independent murine biopsies. B - TEM images of control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 SC. Scale bars= 200 nm. Images are representative of at least two independent murine
biopsies per genotype. C - Quantiﬁcation of corneocyte height: the two corneocytes closest to the SG-SC junction were measured. D - Quantiﬁcation of corniﬁed envelope thickness. SB, SG
and SC layers are indicated. ** p≤ 0.01, *** p≤ 0.001, ****p≤ 0.0001.
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Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 SC suggests there is a reduction in
lipids secreted by LBs, further supporting the conclusion there are LB
biogenesis and/or secretion defects in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/
ﬂERT2 mice.
4. Discussion
4.1. Vps33b and Vipar deﬁcient mice develop a skin phenotype similar to
ARC syndrome patients
VPS33B and VIPAR deﬁciencies lead to range of human phenotypes
that always include ichthyosis [3,7]. Here we demonstrate that both
Vps33b and Vipar deﬁcient mice develop a skin disease that is similar to
patients with ARC syndrome, with keratinocyte hyperplasia and hy-
pertrophy, hypergranulosis, hyperkeratosis and ultrastructural defects
in the SC. This demonstrates that Vps33b and Vipar deﬁcient mice are
suitable models to better understand the molecular mechanisms un-
derlying the pathology of ARC syndrome skin disease. We demonstrate
several defects in Vps33b and Vipar deﬁcient murine epidermis in-
cluding in keratinocyte diﬀerentiation, lamellar body function, base-
ment membrane structure and integrin dependent functions.
4.2. Vps33b and Vipar deﬁcient mice have notable defects in keratinocyte
diﬀerentiation
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 murine epidermis demonstrated
formation of all keratinocyte layers of the epidermis, Fig. 1D, however,
the epidermis was increased in thickness, Fig. 1E, and the basally ex-
pressed keratin 14 was not downregulated in suprabasal cells, Fig. 2A.
The SC is the culmination of keratinocyte diﬀerentiation and the in-
creased size of corneocytes of the SC with decreased thickness of the
corniﬁed envelope, Fig. 2C-E, suggests defects in terminal
Fig. 3. Vps33b and Vipar deﬁcient skin disease is not caused by defects in epidermal junctions. A - Claudin-1 and E-cadherin staining in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin
sections, counterstained with DAPI. Scale bars= 20 μm. Dermo-epidermal junction (dashed line). B - β-catenin staining in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin sections
counterstained with DAPI. Scale bars= 20 μm. Immunoﬂuorescent images are single z-slices from a z-stack and are representative of results from at least six control and three Vps33bﬂ/
ﬂERT2 and Vipas39ﬂ/ﬂERT2 independent murine biopsies. C - TEER readings of control and Vps33bﬂ/ﬂERT2 keratinocyte cultures. Results from two experiments are shown with diﬀerent
symbols. D - TEER readings of individual control Vipas39ﬂ/ﬂERT2 keratinocyte cultures. E - TEM images of desmosomes between adjacent keratinocytes in control, Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 epidermis. Scale bars= 400 nm. TEM images are representative of at least two independent murine biopsies per genotype.
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diﬀerentiation. The SC is also a major component of the water barrier of
the epidermis [41], and defects in the structure of the SC may explain
the decreased water barrier function of Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/
ﬂERT2 skin, Fig. 1C.
4.3. Vps33b and Vipar deﬁcient mice have abnormal lamellar body
formation
The secretion of LB contents is vital for both the formation and
maintenance of the structure and function of the SC and the epidermal
water barrier [42]. It has been previously suggested that LB biogenesis
and secretion might be aﬀected by VPS33B deﬁciency in patients with
ARC and ARKID syndromes [7,10]. We show that in addition to SC
defects in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 murine epidermis,
Fig. 2C-E, which may be caused by defects in LB function, LB
ultrastructure is also altered in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2
epidermis, Fig. 6A, with bubble-like inclusions amongst the lipid layers.
Decreased expression and altered localisation of the LB cargo protein
KLK5, Fig. 6B, and reduced amounts of lipid in the SC, Fig. 6C, also
indicate defects in LB biogenesis. This is unexpected in an epidermis
with increased water loss, as a defective water barrier has been linked
to increased lipid synthesis and lamellar body secretion to promote
recovery of the barrier [43]. There is likely, therefore, to be a defect in
lipid synthesis or secretion in Vps33b and Vipar deﬁcient murine skin.
The roles of VPS33B and VIPAR in LB function may be direct, in LB
formation, delivery of LB contents to LBs, LB secretion or may be in-
direct. There was no accumulation of LB in the SG of Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 epidermis, which suggests there is not a defect in LB
secretion, although this cannot be completely ruled out. Roles for
VPS33B and VIPAR beyond LB biogenesis have been identiﬁed in
Fig. 4. - Vps33b and Vipar deﬁcient murine skin does not show gross changes in the morphology of dermal collagen ﬁbres but areas of thin basement membrane suggest subtle defects in
collagen structure. A - Picrosirius red staining of control (Vps33b+/+ and Vipas39+/+), Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin. In picrosirius red images collagen stains red. Images are
representative of results from three independent murine biopsies per genotype. B - TEM images of collagen ﬁbrils in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 dermis. All images are
0.8 μm2. Images are representative of at least two independent murine biopsies per genotype. C - TEM images of the dermo-epidermal junction in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/
ﬂERT2 skin. Areas of thinner basement membrane (arrow). All images are 1 μm2. SB and dermis (D) are indicated. Images are representative of at least two independent murine biopsies
per genotype.
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several systems [5,21,22], therefore, the skin phenotype in VPS33B and
VIPAR deﬁciency may also be aﬀected by defects in other VPS33B-
VIPAR dependent pathways and not solely LB dysfunction.
4.4. Vps33b and Vipar deﬁcient mice have subtle changes in basement
membrane structure
VPS33B and VIPAR also have an important role in collagen
homeostasis, ensuring LH3 delivery to intracellular collagen [21]. De-
fective LH3 delivery and collagen homeostasis in patients with ARKID
syndrome [7], suggested that defects in collagen homeostasis, such as in
the basement membrane of the skin, could be aﬀecting epidermal
homeostasis.
Analyses of the overall organisation of the dermis, Fig. 4A, and
collagen I ﬁbres in the dermis, Fig. 4B, did not show defects in the
overall organisation of these structures in vivo. However, basement
Fig. 5. Vps33b and Vipar knockout aﬀects collagen I de-
position in ﬁbroblasts and ﬁbroblast function. A -
Decellularised matrix from primary murine ﬁbroblast cul-
tures stained for collagen I. Scale bars= 200 μm. Images
are maximum projections of a z-stack. Three images of two
independent matrices analysed per genotype. B – Standard
deviation (SD) of the Gaussian function of Directionality
analysis of ﬁbres in “A”. C - Range (Max - Min) of the
Gaussian function of Directionality analysis of ﬁbres in ‘A’.
ns p > 0.05, * p≤ 0.05, **** p≤ 0.0001. D - Full thick-
ness skin models of control or Vipas39ﬂ/ﬂERT2 primary ﬁ-
broblasts with control or Vps33bﬂ/ﬂERT2 primary keratino-
cytes stained with H&E, and anti-KLK5. H&E scale
bar= 20 μm, KLK5 scale bar= 50 μm. Images are re-
presentative of at least three full thickness models.
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Fig. 6. Vps33b and Vipar deﬁcient murine epidermis shows
defects in LB function. A – TEM images of the SG-SC junc-
tion in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epi-
dermis. Bubble-like inclusion (single arrow), abnormal
membrane structures (double arrow). Scale bars= 200 nm.
Images are representative of at least two independent
murine biopsies per genotype. B - TEM images of SG cells in
control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis.
Scale bars= 200 nm. Images are representative of at least
two independent murine biopsies per genotype. C - KLK5
staining in control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin
sections, counterstained with DAPI. All KLK5 images were
taken with the same microscope settings, the brightness
was boosted for the KLK5 DAPI merge to illustrate the lo-
calisation of KLK5 staining. Scale bars= 20 μm. Images are
a maximum projection of a z-stack and are representative of
results from at least six control and three Vps33bﬂ/ﬂERT2
and Vipas39ﬂ/ﬂERT2 independent murine biopsies. D - ORO
staining of control, Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 skin
sections, counterstained with DAPI. Scale bars= 20 μm.
Images are a maximum projection of a z-stack and are re-
presentative of results from at least six control and three
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 independent murine
biopsies. SB, SG and SC layers are indicated.
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membrane continuity was disrupted at the dermo-epidermal junction,
Fig. 4C, consistent with alterations in LH3 delivery to collagen. Col-
lagen I secreted by Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 dermal ﬁbro-
blasts was also deposited in a less organised matrix, Fig. 5A–C, in-
dicating that Vps33b or Vipar deﬁciency does aﬀect dermal ﬁbroblasts
function.
The diﬀerences in matrix organisation between in vitro ﬁbroblast
cultures and dermal sections of Vps33b and Vipar deﬁcient mice may
indicate that dermal collagen morphology in Vps33bﬂ/ﬂERT2 and
Vipas39ﬂ/ﬂERT2 mice are not substantially aﬀected by the knockout of
Vps33b or Vipar post-development. These structures may not have
turned over in the 4–5weeks after induction of the knockout; corneo-
cyte formation has been estimated to take 12 days after keratinocytes
leave the stratum basale [44], whereas, collagen VII half-life in the
dermo-epidermal junction has been reported to be about 30 days [45].
This could indicate epidermal defects in Vps33b and Vipar deﬁciency
may present before defects in dermal structures and suggests that al-
though VPS33B and VIPAR are important for collagen homeostasis
through delivery of LH3 to collagen [21], changes in dermal collagen
may not be the primary defect leading to the epidermal phenotype in
Vps33b and Vipar deﬁcient mice. This is also supported by the inability
of control ﬁbroblasts to rescue epidermal defects in KLK5 localisation
and expression in co-culture with ﬁbroblasts from Vps33b and Vipar
deﬁcient mice.
4.5. Vps33b and Vipar deﬁcient ﬁbroblasts have subtle changes in integrin
function
VPS33B is reported to interact with β-integrins for endocytosis and
integrin function [20]. In our Vps33b and Vipar deﬁcient mice we as-
sessed integrin dependent functions of cell spreading and wound
healing. Cell spreading was unaﬀected by Vps33b and Vipar deﬁciency
and wound healing was only signiﬁcantly aﬀected in Vps33bﬂ/ﬂERT2
ﬁbroblasts, indicating that there may be subtle but potentially im-
portant alterations in integrin traﬃc that may aﬀect epidermal func-
tion.
4.6. Vps33b and Vipar deﬁcient mice do not show junctional defects
VPS33B and VIPAR aﬀect junction formation in some polarised cell
types, including kidney cell lines [2] and hepatocytes [22], therefore it
could be hypothesized defects in epidermal junctions in Vps33bﬂ/ﬂERT2
and Vipas39ﬂ/ﬂERT2mice would aﬀect epidermal homeostasis and water
barrier function. However, epidermal junctions were unaﬀected in
Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 mice; tight junction and adherens
junction proteins localised to the plasma membrane, Fig. 3A and B,
tight junction function, as a barrier to ion movement, was not aﬀected
in primary keratinocyte cultures, Fig. 3C and D, and desmosome
structure appeared normal, Fig. 3E. This is consistent with a role for
VPS33B and VIPAR in LB and SC function which is not caused by
changes in epidermal junctions.
5. Conclusions
VPS33B and VIPAR deﬁciencies lead to severe phenotypes in hu-
mans, in ARC and ARKID syndrome [3,7], and in mice, with con-
stitutive knockout of Vps33b causing embryonic lethality [19,21]. This
suggests essential functions for VPS33B and VIPAR, and, due to their
ubiquitous expression, perhaps a ubiquitous function. However, diverse
roles have been reported for VPS33B and VIPAR including mega-
karyocyte α-granule formation [5,19], platelet integrin recycling [20],
LH3 delivery to collagen in kidney cells and ﬁbroblasts [21], Rab11a-
dependent apical protein targeting in hepatocytes [2,22], exosome
maturation [23] and LB formation in the epidermis [7,10]. This in-
dicates that VPS33B and VIPAR do have essential functions in mam-
malian biology, but their roles may be cell-type speciﬁc; ensuring post-
Golgi protein delivery to diverse organelles.
In this study, we add to our knowledge of the pathology of Vps33b
and Vipar deﬁcient mice, demonstrating a range of abnormalities in
Vps33b and Vipar deﬁcient murine skin. Keratinocyte terminal diﬀer-
entiation was visible in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis
but the formation of the SC layer was altered, LB structure and locali-
sation of a LB cargo was aﬀected, the continuity of the basement
membrane at the dermo-epidermal junction was disrupted, isolated ﬁ-
broblasts secreted more disorganized collagen matrices, and Vps33bﬂ/
ﬂERT2 ﬁbroblasts migrated slower in wound healing assays. The subtle
changes in collagen structure and integrin function may aﬀect epi-
dermal function and keratinocyte diﬀerentiation, however, gross col-
lagen ﬁbril structure in the dermis was unaﬀected by the depletion of
the Vps33b or Vipar and control ﬁbroblasts did not rescue epidermal
phenotypes of knockout keratinocytes, indicating that these defects
may not be a primary cause of the epidermal phenotypes in Vps33b and
Vipar deﬁcient mice and suggests an epidermis-speciﬁc, and potentially
LB formation-speciﬁc, role for VPS33B and VIPAR. A potential role for
VPS33B in cytokine production was not explored but may be important
in further study of the Vps33b deﬁcient skin phenotype as elevated
cytokine levels can aﬀect keratinocyte fates [46,47].
Few traﬃcking proteins have been convincingly linked to the bio-
genesis and secretion of LBs; some evidence suggests LBs are formed
from the TGN and form a tubulo-reticular cisternal membrane system
towards the apical surface of keratinocytes, that may be connected to
the apical plasma membrane [48]. However, there is also evidence to
suggest that SNARE-mediated vesicular fusion events are required for
correct LB structure and secretion, as a vesicular fusion protein SNAP29
has been implicated in this process. Epidermal deﬁciency of SNAP29
also causes hyperproliferation with acanthosis and hyperkeratosis, de-
fects in epidermal diﬀerentiation, abnormal formation of LBs and re-
duced LB contents at the SG-SC junction [49]. Rab11a is also associated
with LBs in the epidermis [50], is essential for LB biogenesis [51], and
interacts with VPS33B and VIPAR [2]. This may indicate a common
pathway for VPS33B, VIPAR, Rab11a and SNAP29 in epidermal
homeostasis and LB formation.
VPS33B and VIPAR deﬁciency aﬀects epidermal homeostasis and
water barrier function in murine models. Alterations in epidermal
junctions and gross changes in collagen morphology in the dermis were
not evident in Vps33bﬂ/ﬂERT2 and Vipas39ﬂ/ﬂERT2 epidermis, but LB
formation and production of the lipid lamellae of the SC were aﬀected.
This indicates an epidermal-speciﬁc role for the VPS33B-VIPAR con-
taining tethering complex. Whether this complex is required for LB
formation, delivery of cargo to LBs or LB fusion at the plasma mem-
brane remains to be determined. VPS33B and VIPAR have various re-
ported roles in distinct cell types [2,5,19–22] and we describe a further
cell-type speciﬁc role in the function of epidermal LBs.
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